Company intelligence / Profile preview

Sanyou Biopharmaceuticals

Minhang District, Shanghai, Chinasanyoubio.com ↗
Ownership
Private
Employees
~350
Development stage
Preclinical
01

Overview

Sanyou has a broad preclinical pipeline with multiple bispecific and monoclonal antibodies in discovery or preclinical stages targeting infectious diseases like COVID‑19 and monkeypox as well as oncology and autoimmune indications. The company’s platforms have enabled rapid response to public health crises; at least nine collaborative projects have obtained IND approval. Its technologies are widely used by global partners for both research-use-only reagents and therapeutic development.

Therapeutic areas
OncologyMetabolic DisordersImmunologyInfectious Diseases
Modalities
Monoclonal antibodyBispecific antibodyAntibody-drug conjugateRecombinant proteinNanobody therapy
Industry
Biotech
02

Drug pipeline

3 assets

huMIA-2

Preclinical

2 more assets in the full pipeline.

Request access →
03

Partnerships

Medicovestor Inc.: Strategic partnership on chemoimmunotherapy ADC development using proprietary ADC platforms combined with Sanyou’s AI-STAL technology for oncology/autoimmune indications.JiAnTeBo Biotechnology Co., Ltd.: Partnership on agonist antibodies targeting metabolic disorders including obesity, diabetes, Alzheimer’s disease using Super-trillion phage display platform.Over one thousand pharmaceutical companies globally as clients or collaborators including major pharma/biotech firms worldwide.

Beyond the preview

Go deeper on Sanyou Biopharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanyou Biopharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call